130 likes | 268 Views
R&D Accounting. Ewa Nelip. Problem 1. Expensing vs. Capitalizing Enterprise Income. RNEA. Expensing R&D. Capitalizing R&D. When we expense R&D RNEA is negative in the first 3 years. It gradually increases from -85% to 75%
E N D
R&D Accounting Ewa Nelip
RNEA Expensing R&D Capitalizing R&D • When we expense R&D RNEA is negative in the first 3 years. It gradually increases from -85% to 75% • When we capitalize it, it is positive throughout all the years. The range is a lot smaller, it goes from 5.45% to 15.79% • The changes are due to differences in the net operating assets
Differences in Valuation • The value of the firm is the same (334) under both accounting methods • The present value of the sum of residual income is negative under expensing method and slightly positive if we capitalize R&D • Under capitalization the continuing value constitutes most of the firm value. • If we tried to value this firm by forecasting only to 2016 our valuation would be distorted as we have not reached a steady state in both cases. Moreover, the residual income is still negative for the expensing method.
3- versus 5-year Depreciation • In 2017 company looks more profitable under the 3-year depreciation. The EPAT is 1,189 compared to 1,109 if we expect the assets to have 5 years estimated useful life.
Intrinsic Value of the Firm with 3-year Estimated Assets Life
Intrinsic Value of the Firm with 5-year Estimated Assets Life